Malaria Ag Rapid Testing Market Share

North American Market Forecast

The North America malaria ag rapid testing market is estimated to hold 30% of the revenue share by 2036. This growth is set to be dominated by rising travelers returning to North America. Furthermore, with about 45% of US corporate travelers doing more trips than they did prior to the epidemic, business travel is returning. However, this has further led to an increase in malaria cases. Most of the people in North America visit regions such as the Middle East & Africa which is the hotspots for malaria prevalence. Hence, these travelers return back with the infection hence boosting the malaria rate. Every year, travel to malaria-endemic regions including sub-Saharan Africa, parts of South America, and Southeast Asia is linked to between 1,999 and 2,500 cases of malaria in the country; nevertheless, over 8 locally transmitted cases this year have been reported by individuals who haven't recently visited these regions. There were about 6 instances reported in Florida and one in each of Maryland and Texas. Hence, it has also been estimated that this region has recorded its first homegrown malaria cases. Therefore, the market for malaria ag rapid testing market is set to rise in this region.

European Market Analysis

The malaria ag rapid testing market in Europe is also expected to experience significant growth over the forecast period. Fifty years after being eradicated, malaria remains a serious health threat in Europe. Furthermore, there has been rigorous launch of vaccines in this region by various key players and number of researches has taken place in order to eradicate completely. As a result, this market is poised to grow in this region.